#CaringforLife #CiplaAt90 #HealthcareAccess #Yurpeak #Tirzepatide #DiabetesManagement #ObesityTreatment Cipla launches Yurpeak (tirzepatide), a one-weekly injectable therapy for managing obesity and type 2 diabetes mellitus (T2DM) two of the countrys most pressing health challenges
FDA Approved Semaglutide has become a sought after treatment of choice for significant weight loss results
This oxidative stress is a significant factor in the development of alcoholic liver disease, a condition where the liver gets damaged due to alcohol consumption
The mL markings on a 3 mL syringe are less precise than insulin syringe unit markings, so insulin syringes are preferred whenever the volume fits
Most patients are comfortable selfinjecting at home after simple training, but inoffice administration can be arranged based on preference
Tool: Avoiding Nausea (00:22:24) Cerebellum, Motor Coordination & Learning (00:23:17) Cerebellar Function, Precision & Timing of Movement